Prognosis of prostate sarcoma

Prostate sarcoma course of fast, rapid growth, more bad prognosis, especially children with poor prognosis, diagnosis, most patients do not survive more than one year. Rhabdomyosarcoma high degree of malignancy, the fastest growth, almost all died within a year; leiomyosarcoma and fibrosarcoma growth slow, and somewhat better prognosis, the average survival is 2 to 3 years. Infant and child development and transfer of prostate sarcoma rapidly and extensively than adults, from the beginning of symptoms to have killed an average of 10 children under the age of 3 months, and adults about one year. In recent years, as a result of surgery, radiotherapy and chemotherapy, the prognosis of children rhabdomyosarcoma has changed. Limitations on the lesions, surgery after chemotherapy for 2 years, the disease-free survival rate of children up to 54%. This progress enabled people to see hope.